Boston, MA 06/05/2013 (wallstreetpr) – The share prices of Ampio Pharmaceuticals Inc. (NASDAQ:AMPE) had surged by 12.56 percent to close at $6.75 per share for the end of last trading session on Tuesday. The shares of the pharmaceutical company had been trading in the range of $5.85 to $6.92 per share during the day. This recent surge in share prices had pushed Ampio Pharmaceuticals Inc. (NASDAQ:AMPE) to hit new peaks with the 52 week high price level recorded at $6.92 per share and the 52 week low price level of the company is at $2.55 per share.
The development stage pharmaceutical company focuses on the development and commercialization of treatment therapies to prevent inflammatory conditions, for which the treatment therapies at present are very rare. The range of diseases focused by Ampio Pharmaceuticals Inc. (NASDAQ:AMPE) for drug and treatment therapies development include eye disease, kidney disease, metabolic disorders, chronic and acute inflammatory diseases.
Ampio Pharmaceuticals Inc. (NASDAQ:AMPE) focuses on developing commercializing drugs and treatment therapies for such diseases with minimal side effects. The company had recently been surging in share prices to touch new peaks owing to the company updates released recently to throw insights into the status of its different product candidates.
Ampio Pharmaceuticals Inc. (NASDAQ:AMPE) had witnessed a heavy trading volume of 1.2 million shares on Tuesday, while the average trading volume is at 255,259 shares per day. The development stage pharmaceutical company presently holds 37.09 million shares outstanding with an institutional ownership of 21 percent of its holdings.
